TCPTP inactivation contributes to NASH and fibrosis via a STAT-1-dependent pathway, in contrast to HCC, which is promoted by a STAT-3-dependent pathway (Figure 2B) [116]. This evidence concerns the gene STAT3 and hepatocellular carcinoma.